Wikidata

(Q40058976)

English

Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft model.

scientific article published on November 2007

In more languages

Statements

title
Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft model (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17975157
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17975157%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40058976&oldid=1566596345"